Bienville Capital Management, LLC Gsk PLC Transaction History

Bienville Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $244,014 - $262,469	-6,031 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$39.4 - $42.7 $2,048 - $2,220	52 Added 0.87%	6,031 $244,000
Q1 2019 May 13, 2019	SELL	$38.57 - $42.69 $1,349 - $1,494	-35 Reduced 0.58%	5,979 $253,000
Q4 2018 Feb 13, 2019	BUY	$37.8 - $42.69 $25,439 - $28,730	673 Added 12.6%	6,014 $233,000
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $198 - $213	-5 Reduced 0.09%	5,341 $217,000
Q2 2018 Aug 08, 2018	BUY	$39.61 - $42.76 $10,258 - $11,074	259 Added 5.09%	5,346 $218,000
Q1 2018 May 15, 2018	SELL	$36.18 - $40.15 $123,301 - $136,831	-3,408 Reduced 40.12%	5,087 $204,000
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $16,574 - $19,651	-469 Reduced 5.23%	8,495 $306,000
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $353,540 - $372,454	8,964	8,964 $368,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bienville Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bienville Capital Management, LLC with notifications on news.